Engineered immune cells take on Hard-to-Treat lymphoma
Disease control
Ongoing
This early-phase study tests whether a patient's own immune cells, modified in a lab to recognize and attack lymphoma cells, can shrink tumors or stop the cancer from growing. The treatment is for people with non-Hodgkin lymphoma that has not responded to or has returned after at…
Phase: PHASE1 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated May 02, 2026 07:25 UTC